Cyfuse Biomedical K.K. Company Description

Cyfuse Biomedical K.K. engages in the development, manufacture, and sale of regenerative medicine products in Japan.

It develops cellular products in the field of regenerative therapy; and undertakes contract for cellular products for research and development.

The company also offers Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bones, blood vessels, and nerves; regenova, a bio 3D printer for 3D stacking of cells; and S-PIKE that develops 3D-structures from cells.

Cyfuse Biomedical K.K. was incorporated in 2010 and is based in Tokyo, Japan.

Cyfuse Biomedical K.K.

Country	Japan
Founded	2010
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	21
CEO	Shizuka Akieda

Contact Details

Address: Sumitomo Fudosan Mita Twin Building Tokyo, 108-6301 Japan
Phone	81 3 6435 1885
Website	cyfusebio.com

Stock Details

Ticker Symbol	4892
Exchange	Tokyo Stock Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	JPY
ISIN Number	JP3311800001
SIC Code	3841

Key Executives

Name	Position
Shizuka Akieda	Chief Executive Officer
Masahiro Sanjo	Chief Financial Officer